Company
About the company
AtriCure UK distributes medical devices used by clinicians treating atrial fibrillation and related cardiac conditions. Its portfolio supports surgical and minimally invasive ablation, left atrial appendage management and pain management after surgery, alongside professional education and product resources for healthcare teams. The UK entity serves hospitals and medical professionals without operating a domestic manufacturing site or dedicated office.
Company statement
Carbon claim
AtriCure UK reports 2025 emissions of 104.23 tCO2e, 15% below 2024, and commits to net-zero emissions by 2050.
A short summary of publicly available information. We have not verified the carbon claim.
Read the public source